A local startup is working with the Mayo Clinic to advance its skin imaging and diagnostics technology.
Triangulate Labs entered into a licensing agreement with the renowned medical center to develop its SkinMap technology, an artificial intelligence-powered total body photography system that helps dermatologists find and cure skin cancer earlier. Under the terms of the deal, the Mayo Clinic will offer guidance to Triangulate Labs as it develops the product and remove barriers to patient access.
Trending: Beachfront restaurant in Broward files for bankruptcy
“We are thrilled to have the opportunity to work with such talented faculty who show amazing dedication to patient care and enthusiasm for the research needed to make care even better,” said co-founder William Hall.
Founded in 2022, Triangulate labs is based at the Research Park at Florida Atlantic University in Boca Raton.
The Skinmap system uses a mobile device to capture hundreds of high-resolution images of a patient's skin in less than a minute. From there, its algorithms review each image pixel and matches it to the location on the body, making it possible to create a detailed 3D map of the skin.
Headquartered in Rochester, Minnesota, the nonprofit Mayo Clinic is the nation’s top-ranked hospital. It also has campuses and facilities across the U.S, including Jacksonville.
Diagnosing and treating skin cancer early is a major concern in locations like Florida, which has one of the highest rates of melanoma in the U.S. About one in five Americans will develop skin cancer in their lifetime, according to the American Cancer Society
Related: DermaSensor exec on bringing skin cancer detection device to market
Ignoring signs of skin cancer can have deadly consequences. Melanoma, the most aggressive form of the disease, has a 99% five-year survival rate if treated early. If not, it can spread to other parts of the body and may not be curable.
Triangulate Labs isn't the only local company focused on finding better ways to diagnose and treat skin cancer. Miami-based DermaSensor recently began deploying its handheld skin cancer detection tool to physicians after it achieved U.S. Food and Drug Administration clearance in January.
For more stories like this one, sign up for Miami Inno newsletters from the South Florida Business Journal and the American Inno network.
